SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

BMC Cancer. 2009;9:73.

The role of PET/CT in detection of gastric cancer recurrence.

, , , , , , , , , ,

제1저자 심성훈 · 교신저자 오도연

소속 (1)
  1. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. boron@hanmail.net

Abstract

BACKGROUND In the course of surveillance of gastric cancer recurrence after curative resection, contrast CT scan is used in general. However, new findings from CT scan are not always confirmatory for the recurrence. In this case, we usually use short-term follow up strategy or therapeutic intervention with clinical decision. Recently, the use of fusion Positron Emission Tomography/Computed Tomography (PET/CT) is increasing. The purpose of this study is to evaluate the efficacy and usefulness of PET/CT for detecting recurrence of gastric cancer after curative resection.

METHODS Fifty two patients who received curative resection of gastric cancer and had undergone PET/CT and contrast CT for surveillance of recurrence until Dec 2006 in Seoul National University Hospital were analyzed retrospectively. Recurrence of gastric cancer was validated by histologic confirmation (n = 17) or serial contrast CT follow up with at least 5 month interval (n = 35). McNemar's test and Fisher's exact test were used to evaluate sensitivity and specificity of PET/CT and contrast CT.

RESULTS Of 52 patients, 38 patients were confirmed as recurrence. The sensitivity was 68.4% (26/38) for PET/CT and 89.4% (34/38) for contrast CT (p = 0.057). The specificity was 71.4% (10/14) and 64.2% (9/14), respectively (p = 1.0). In terms of the recurred sites, the sensitivity and specificity of PET/CT were similar to those of contrast CT in all sites except peritoneum. Contrast CT was more sensitive than PET/CT (p = 0.039) for detecting peritoneal seeding. Additional PET/CT on contrast CT showed no further increase of positive predictive value regardless of sites. Among 13 patients whose image findings between two methods were discordant and tissue confirmation was difficult, the treatment decision was made in 7 patients based on PET/CT, showing the final diagnostic accuracy of 42.8% (3/7).

CONCLUSION PET/CT was as sensitive and specific as contrast CT in detection of recurred gastric cancer except peritoneal seeding. However, additional PET/CT on contrast CT did not increase diagnostic accuracy in detection of recurred gastric cancer. Further studies are warranted to validate the role of PET/CT in detection of gastric cancer recurrence.

Figures

Figure 1
Figure 1 Treatment decision by findings from fusion PET/CT when tissue confirmation is impossible. When the image findings between the two methods were discordant, treatment decision was made according to the PET/CT findings in 7 out of 13 cases (Figure 1). But its final accuracy was 42.8% (3/7).
Figure 2
Figure 2 Contrast CT and PET/CT with lymph node recurrence. (A) Prominent lymph node in contrast CT suggesting recurrence (arrow) (B) PET/CT finding without hypermetabolic lesions suggesting absence of tumor recurrence (C) Increased previous lesion (arrow) after 6 months.

그림 출처: PubMed Central 공개 논문 (PMC2651906)

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
BMC cancer · eISSN 1471-2407
전자 출판
2009-03-01
MeSH
Adult · Aged · Aged, 80 and over · Female · Fluorodeoxyglucose F18 · Humans · Male · Middle Aged · Neoplasm Recurrence, Local / diagnostic imaging · Positron-Emission Tomography / methods · Radiopharmaceuticals · Sensitivity and Specificity · Stomach Neoplasms / diagnostic imaging / surgery · Tomography, X-Ray Computed / methods
Substances
Radiopharmaceuticals · Fluorodeoxyglucose F18
참고문헌
22편